Tony has now had four weeks on Enzalutamide, as his PSA was rocketing up again despite the Decapeptyl. He has just had a blood test, showing that:
1. PSA down from >130 to 18 (hooray!)
2. Alkaline phosphatase has continued to rise, and has doubled to 3500 (boo!)
So what are we to think? He feels quite well and is currently building a fence in the garden, although he's still taking hefty doses of painkillers, not daring to stop these until he's seen the oncologist.
This appointment is on Monday (in 2 days), so it's not long to wait, but we want to have the right questions, and possibly the right answers if he is offered choices, at the consultation. If anyone can suggest why there's this discrepancy in his progess, and what this might mean re further treatment, we'd appreciate your thoughts and opinions.
When the Enza was started, the oncologist was talking about adding in Radium 223 and possibly Zometa, if the Enza was helping. That sounds like a heavy load of treatments to be facing, but perhaps this will be necessary?
Or could it be a liver problem, and if so, why would this arise now, and would it cause any other symptoms?
Marje